42 related articles for article (PubMed ID: 19234510)
1. Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma.
Crocchiolo R; Ringden O; Bay JO; Blaise D; Omasic B; Mazzi B; Picard C; Trinca S; Barkholt L; Peccatori J; Gregori S; Amodio G; Fleischhauer K; Ciceri F; Bregni M
Bone Marrow Transplant; 2018 Feb; 53(2):213-218. PubMed ID: 29131154
[TBL] [Abstract][Full Text] [Related]
2. Is allogeneic transplant for solid tumors still alive?
Bregni M; Badoglio M; Pedrazzoli P; Lanza F
Bone Marrow Transplant; 2016 May; 51(5):751-2. PubMed ID: 26808572
[No Abstract] [Full Text] [Related]
3. Role of immunotherapy for renal cell cancer in 2011.
George S; Pili R; Carducci MA; Kim JJ
J Natl Compr Canc Netw; 2011 Sep; 9(9):1011-8. PubMed ID: 21917625
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC).
Bregni M; Ciceri F; Peccatori J
J Cancer; 2011; 2():347-9. PubMed ID: 21716855
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after.
Tykodi SS; Sandmaier BM; Warren EH; Thompson JA
Expert Opin Biol Ther; 2011 Jun; 11(6):763-73. PubMed ID: 21417772
[TBL] [Abstract][Full Text] [Related]
6. Combining allogeneic immunotherapy with an mTOR inhibitor for advanced renal cell carcinoma.
Tykodi SS; Voong LN; Warren EH
Bone Marrow Transplant; 2010 Aug; 45(8):1360-2. PubMed ID: 19966847
[No Abstract] [Full Text] [Related]
7. Allogeneic stem cell transplantation for renal cell carcinoma.
Bregni M; Herr W; Blaise D;
Expert Rev Anticancer Ther; 2011 Jun; 11(6):901-11. PubMed ID: 21707287
[TBL] [Abstract][Full Text] [Related]
8. EORTC-GU group expert opinion on metastatic renal cell cancer.
de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.
Nakagawa T; Kami M; Hori A; Kim SW; Murashige N; Hamaki T; Kishi Y; Fujimoto H; Matsuoka N; Okajima E; Komiyama M; Tobisu K; Wakayama T; Uike N; Tajima K; Makimoto A; Mori S; Tanosaki R; Takaue Y; Kakizoe T
Exp Hematol; 2004 Jul; 32(7):599-606. PubMed ID: 15246155
[TBL] [Abstract][Full Text] [Related]
10. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
Childs R; Chernoff A; Contentin N; Bahceci E; Schrump D; Leitman S; Read EJ; Tisdale J; Dunbar C; Linehan WM; Young NS; Barrett AJ
N Engl J Med; 2000 Sep; 343(11):750-8. PubMed ID: 10984562
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience.
Artz AS; Van Besien K; Zimmerman T; Gajewski TF; Rini BI; Hu HS; Stadler WM; Vogelzang NJ
Bone Marrow Transplant; 2005 Feb; 35(3):253-60. PubMed ID: 15543195
[TBL] [Abstract][Full Text] [Related]
12. Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity.
Massenkeil G; Roigas J; Nagy M; Wille A; Stroszczynski C; Mapara MY; Loening S; Dörken B; Arnold R
Bone Marrow Transplant; 2004 Aug; 34(4):309-16. PubMed ID: 15220955
[TBL] [Abstract][Full Text] [Related]
13. Relationship between tumor-infiltrating T lymphocytes and clinical response after reduced-intensity allogeneic hematopoietic stem cell transplantation for advanced renal cell carcinoma: a single center prospective study.
Ishiyama K; Takami A; Suzuki S; Konaka H; Namiki M; Ooi A; Nakao S
Jpn J Clin Oncol; 2009 Dec; 39(12):807-12. PubMed ID: 19770130
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting.
Bregni M; Bernardi M; Servida P; Pescarollo A; Crocchiolo R; Treppiedi E; Corradini P; Ciceri F; Peccatori J
Bone Marrow Transplant; 2009 Aug; 44(4):237-42. PubMed ID: 19234510
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
